Wei Bin, Ph. D.
He acquired his Ph.D. degree in Institute of Virology, Chinese Center of Disease Control (Chinese CDC, National Academy of Preventive Medicine) in Beijing, China in 2001.Then he experienced his postdoctor-al training in the UK (University of Cambridge,University of Oxford,& Imperial College London ) . He moved back to China in 2009 and worked in State key laboratory of Cell Biology, Institute of Biochemistry and Cell Biology (SIBCB), Shanghai Institutes for Biological Sciences (SIBS) in Chinese Academy of Science (CAS) as an associate profe-ssor.In 2012, he joined the Asian Veterinary Research Center in Boehringer-Ingelheimas a senior scientist and an international project leader. In 2014, he joined in Wuhan Institute of Virology (WHIOV), CAS as an independent Principal Investigator.
The lab of Adaptive Immunity will have broadened interests on the investigation of novel signal protein complexes and their regulatory roles in lymphocytes, especially in T cells. Appropriate formation and function of cell surface, cytosolic and nuclear signal protein complex in lymphocytes are essential for the correct and efficient functioning of different type of cells and organs. Dysfunction of these complexes play critical role in the pathogenesis of complicated human diseases including autoimmune diseases, inflammatory diseases, immunity deficiency, cancer, pathogens invading induced infectious diseases, and so on. The aim of the lab is to reveal the function of novel protein complexes and epigenetic regulatory mechanisms. Accordingly, the lab has interests in the following research fields : (1) signaling transduction during T cell activation and differentiation; (2) viral transmission between cells in vivo and in vitro; (3) inflammation in chronic human diseases; (4) and inflammation in human infectious diseases.